Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Evolutionary Paradigms from Ancient and Ongoing Conflicts between the Lentiviral Vif Protein and Mammalian APOBEC3 Enzymes.

Harris RS, Anderson BD.

PLoS Pathog. 2016 Dec 1;12(12):e1005958. doi: 10.1371/journal.ppat.1005958. eCollection 2016 Dec. Review. No abstract available.

2.

Species-specific differences in the ability of feline lentiviral Vif to degrade feline APOBEC3 proteins.

Yoshikawa R, Nakano Y, Yamada E, Izumi T, Misawa N, Koyanagi Y, Sato K.

Microbiol Immunol. 2016 Apr;60(4):272-9. doi: 10.1111/1348-0421.12371.

3.

New World feline APOBEC3 potently controls inter-genus lentiviral transmission.

Konno Y, Nagaoka S, Kimura I, Yamamoto K, Kagawa Y, Kumata R, Aso H, Ueda MT, Nakagawa S, Kobayashi T, Koyanagi Y, Sato K.

Retrovirology. 2018 Apr 10;15(1):31. doi: 10.1186/s12977-018-0414-5.

4.

Host restriction of lentiviruses and viral countermeasures: APOBEC3 and Vif.

Jónsson SR, Andrésdóttir V.

Viruses. 2013 Jul 30;5(8):1934-47. doi: 10.3390/v5081934. Review.

5.

A conflict of interest: the evolutionary arms race between mammalian APOBEC3 and lentiviral Vif.

Nakano Y, Aso H, Soper A, Yamada E, Moriwaki M, Juarez-Fernandez G, Koyanagi Y, Sato K.

Retrovirology. 2017 May 8;14(1):31. doi: 10.1186/s12977-017-0355-4. Review.

6.

Small ruminant lentiviral Vif proteins commonly utilize cyclophilin A, an evolutionarily and structurally conserved protein, to degrade ovine and caprine APOBEC3 proteins.

Yoshikawa R, Izumi T, Nakano Y, Yamada E, Moriwaki M, Misawa N, Ren F, Kobayashi T, Koyanagi Y, Sato K.

Microbiol Immunol. 2016 Jun;60(6):427-36. doi: 10.1111/1348-0421.12387.

7.

Cellular requirements for bovine immunodeficiency virus Vif-mediated inactivation of bovine APOBEC3 proteins.

Zhang W, Wang H, Li Z, Liu X, Liu G, Harris RS, Yu XF.

J Virol. 2014 Nov;88(21):12528-40. doi: 10.1128/JVI.02072-14. Epub 2014 Aug 20.

8.

Core-binding factor subunit beta is not required for non-primate lentiviral Vif-mediated APOBEC3 degradation.

Ai Y, Zhu D, Wang C, Su C, Ma J, Ma J, Wang X.

J Virol. 2014 Oct;88(20):12112-22. doi: 10.1128/JVI.01924-14. Epub 2014 Aug 13.

9.

Catalytic activity of APOBEC3F is required for efficient restriction of Vif-deficient human immunodeficiency virus.

Albin JS, Brown WL, Harris RS.

Virology. 2014 Feb;450-451:49-54. doi: 10.1016/j.virol.2013.11.041. Epub 2013 Dec 20.

10.

Antiretroviral activity and Vif sensitivity of rhesus macaque APOBEC3 proteins.

Virgen CA, Hatziioannou T.

J Virol. 2007 Dec;81(24):13932-7. Epub 2007 Oct 17.

11.

Conserved and non-conserved features of HIV-1 and SIVagm Vif mediated suppression of APOBEC3 cytidine deaminases.

Zhang W, Huang M, Wang T, Tan L, Tian C, Yu X, Kong W, Yu XF.

Cell Microbiol. 2008 Aug;10(8):1662-75. doi: 10.1111/j.1462-5822.2008.01157.x. Epub 2008 Apr 16.

12.

Lentiviral Vif degrades the APOBEC3Z3/APOBEC3H protein of its mammalian host and is capable of cross-species activity.

Larue RS, Lengyel J, Jónsson SR, Andrésdóttir V, Harris RS.

J Virol. 2010 Aug;84(16):8193-201. doi: 10.1128/JVI.00685-10. Epub 2010 Jun 2.

13.

Interaction between HIV-1 and APOBEC3 sub-family of proteins.

Arriaga ME, Carr J, Li P, Wang B, Saksena NK.

Curr HIV Res. 2006 Oct;4(4):401-9. Review.

PMID:
17073615
14.

Ubiquitination of APOBEC3 proteins by the Vif-Cullin5-ElonginB-ElonginC complex.

Shirakawa K, Takaori-Kondo A, Kobayashi M, Tomonaga M, Izumi T, Fukunaga K, Sasada A, Abudu A, Miyauchi Y, Akari H, Iwai K, Uchiyama T.

Virology. 2006 Jan 20;344(2):263-6. Epub 2005 Nov 21.

15.

Accessory genes confer a high replication rate to virulent feline immunodeficiency virus.

Troyer RM, Thompson J, Elder JH, VandeWoude S.

J Virol. 2013 Jul;87(14):7940-51. doi: 10.1128/JVI.00752-13. Epub 2013 May 8.

17.

Running loose or getting lost: how HIV-1 counters and capitalizes on APOBEC3-induced mutagenesis through its Vif protein.

Münk C, Jensen BE, Zielonka J, Häussinger D, Kamp C.

Viruses. 2012 Nov 14;4(11):3132-61. doi: 10.3390/v4113132. Review.

18.

Productive replication of Vif-chimeric HIV-1 in feline cells.

Stern MA, Hu C, Saenz DT, Fadel HJ, Sims O, Peretz M, Poeschla EM.

J Virol. 2010 Jul;84(14):7378-95. doi: 10.1128/JVI.00584-10. Epub 2010 May 12.

19.

A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif).

Schröfelbauer B, Chen D, Landau NR.

Proc Natl Acad Sci U S A. 2004 Mar 16;101(11):3927-32. Epub 2004 Feb 20.

20.

Human immunodeficiency virus type 1 Vif induces cell cycle delay via recruitment of the same E3 ubiquitin ligase complex that targets APOBEC3 proteins for degradation.

DeHart JL, Bosque A, Harris RS, Planelles V.

J Virol. 2008 Sep;82(18):9265-72. doi: 10.1128/JVI.00377-08. Epub 2008 Jul 2.

Supplemental Content

Support Center